Welcome to our dedicated page for Beyond SEC filings (Ticker: BYON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Beyond Inc.'s SEC filings document operating results, material events, governance matters, shareholder voting matters, and capital-structure disclosures for an ecommerce retail issuer with common stock and warrants. The records include reports filed under the Bed Bath & Beyond, Inc. name and cover the company's Bed Bath & Beyond, Overstock, buybuy BABY, Kirkland's and Kirkland's Home brands, related websites, and blockchain asset portfolio.
Recent filings include Form 8-K and 8-K/A disclosures for financial results, material definitive agreements, completed acquisition activity, and references to Form S-4 registration materials and joint proxy/prospectus filings. They also document the completed acquisition of The Brand House Collective, shareholder-vote matters, securities issued in transactions, and governance and capital-structure changes affecting the retail brand portfolio.
Amplify Investments LLC and Amplify ETF Trust reported beneficial ownership of 7,421,717 shares of Bed Bath & Beyond, Inc. common stock, representing 10.70% of the class. The filing lists sole voting and dispositive power over all 7,421,717 shares. The amendment is signed by Jodie L. Crotteau, Chief Compliance Officer, dated 06/02/2026.
Amplify Investments LLC and Amplify ETF Trust reported beneficial ownership of 7,421,717 shares of Bed Bath & Beyond, Inc. common stock, representing 10.70% of the class. The filing lists sole voting and dispositive power over all 7,421,717 shares. The amendment is signed by Jodie L. Crotteau, Chief Compliance Officer, dated 06/02/2026.
BED BATH & BEYOND, INC. director Tamara Ward filed an amended ownership report to correct her previously disclosed holdings. The amendment shows she directly holds 4,676 shares of common stock, which had been unintentionally omitted from her original Form 3 and a subsequent Form 4. No new buy or sell transaction is reported.
BED BATH & BEYOND, INC. director Tamara Ward filed an amended ownership report to correct her previously disclosed holdings. The amendment shows she directly holds 4,676 shares of common stock, which had been unintentionally omitted from her original Form 3 and a subsequent Form 4. No new buy or sell transaction is reported.
Bed Bath & Beyond, Inc. announced leadership changes focused on finance and board governance. The Board appointed Chief Financial Officer Brian LaRose to also serve as principal accounting officer, effective May 15, 2026, replacing Leah Putnam in that role. The company states there are no special arrangements behind his appointment and notes that he has no family ties or related-party transactions with directors or executives that require disclosure.
The Board also appointed Tamara Ward as a director effective May 15, 2026, with her term running until the 2027 annual stockholder meeting or earlier departure. She was named Chair of the Compensation Committee and a member of the Audit Committee. Under the existing non-employee director compensation program, Ward received restricted stock units valued at $165,000 and will earn a $75,000 annual cash retainer, paid quarterly. The company plans to enter into its standard indemnification agreement with her and reports no related-party transactions requiring disclosure.
Bed Bath & Beyond, Inc. announced leadership changes focused on finance and board governance. The Board appointed Chief Financial Officer Brian LaRose to also serve as principal accounting officer, effective May 15, 2026, replacing Leah Putnam in that role. The company states there are no special arrangements behind his appointment and notes that he has no family ties or related-party transactions with directors or executives that require disclosure.
The Board also appointed Tamara Ward as a director effective May 15, 2026, with her term running until the 2027 annual stockholder meeting or earlier departure. She was named Chair of the Compensation Committee and a member of the Audit Committee. Under the existing non-employee director compensation program, Ward received restricted stock units valued at $165,000 and will earn a $75,000 annual cash retainer, paid quarterly. The company plans to enter into its standard indemnification agreement with her and reports no related-party transactions requiring disclosure.
BED BATH & BEYOND, INC. director Tamara Ward reported a compensation-related equity grant. She received 36,105 restricted stock units, each representing a contingent right to receive one share of common stock. These restricted stock units vest at the close of business on May 14, 2027, with vested shares delivered promptly after vesting.
Following this grant, Ward beneficially owns 36,105 restricted stock units from the reported award, all held as a direct interest. This is not an open‑market purchase or sale but a grant, award, or other acquisition as part of her role with the company.
BED BATH & BEYOND, INC. director Tamara Ward reported a compensation-related equity grant. She received 36,105 restricted stock units, each representing a contingent right to receive one share of common stock. These restricted stock units vest at the close of business on May 14, 2027, with vested shares delivered promptly after vesting.
Following this grant, Ward beneficially owns 36,105 restricted stock units from the reported award, all held as a direct interest. This is not an open‑market purchase or sale but a grant, award, or other acquisition as part of her role with the company.
BED BATH & BEYOND, INC. director Tamara Ward filed an initial insider ownership report on Form 3. This filing establishes her status as a reporting person and does not list any share purchases, sales, or other transactions at this time.
BED BATH & BEYOND, INC. director Tamara Ward filed an initial insider ownership report on Form 3. This filing establishes her status as a reporting person and does not list any share purchases, sales, or other transactions at this time.
Bed Bath & Beyond reports results of its 2026 annual meeting. Stockholders approved a Charter amendment doubling authorized common shares from 100,000,000 to 200,000,000, giving the company more flexibility to issue stock in the future.
They also approved an amendment and restatement of the 2005 Equity Incentive Plan, adding 4,291,000 newly authorized shares for employee equity awards, plus additional shares through updated recycling provisions. All director nominees were elected, KPMG LLP was ratified as auditor for 2026, executive compensation received advisory approval, and an adjournment proposal passed but was not used. The meeting had a quorum with 49,326,700 of 69,342,333 eligible shares represented.
Bed Bath & Beyond reports results of its 2026 annual meeting. Stockholders approved a Charter amendment doubling authorized common shares from 100,000,000 to 200,000,000, giving the company more flexibility to issue stock in the future.
They also approved an amendment and restatement of the 2005 Equity Incentive Plan, adding 4,291,000 newly authorized shares for employee equity awards, plus additional shares through updated recycling provisions. All director nominees were elected, KPMG LLP was ratified as auditor for 2026, executive compensation received advisory approval, and an adjournment proposal passed but was not used. The meeting had a quorum with 49,326,700 of 69,342,333 eligible shares represented.
Bed Bath & Beyond’s former Chief Accounting Officer Leah R. Putnam reported multiple equity compensation events in the company’s common stock. On May 14, 2026, she exercised performance shares and restricted stock units into a total of 75,013 shares of common stock, while 18,268 shares were disposed of at $4.69 per share to cover tax liabilities. She also received a grant of 1,068 restricted stock units, which were approved by shareholders on May 14, 2026. Footnotes state that several restricted stock units and performance shares had their vesting accelerated in connection with her departure from the company, with vested shares to be delivered promptly after vesting.
Bed Bath & Beyond’s former Chief Accounting Officer Leah R. Putnam reported multiple equity compensation events in the company’s common stock. On May 14, 2026, she exercised performance shares and restricted stock units into a total of 75,013 shares of common stock, while 18,268 shares were disposed of at $4.69 per share to cover tax liabilities. She also received a grant of 1,068 restricted stock units, which were approved by shareholders on May 14, 2026. Footnotes state that several restricted stock units and performance shares had their vesting accelerated in connection with her departure from the company, with vested shares to be delivered promptly after vesting.
Bed Bath & Beyond director Barclay Corbus reported several equity compensation moves. On May 15, 2026, he exercised 26,873 restricted stock units into common shares, bringing his direct common stock holdings to 105,047 shares.
He also received a new grant of 35,181 restricted stock units on May 14, 2026, which will vest at the close of business on May 14, 2027. In addition, he holds 7,816 common stock warrants originally issued on October 7, 2025, each allowing purchase of one common share at an exercise price of $15.50 per warrant through October 7, 2026.
Bed Bath & Beyond director Barclay Corbus reported several equity compensation moves. On May 15, 2026, he exercised 26,873 restricted stock units into common shares, bringing his direct common stock holdings to 105,047 shares.
He also received a new grant of 35,181 restricted stock units on May 14, 2026, which will vest at the close of business on May 14, 2027. In addition, he holds 7,816 common stock warrants originally issued on October 7, 2025, each allowing purchase of one common share at an exercise price of $15.50 per warrant through October 7, 2026.
Bed Bath & Beyond director William Benjamin Nettles Jr. reported compensation-related equity transactions, with no open-market buying or selling. On May 15, 2026, restricted stock units covering 26,873 shares of common stock vested and were delivered, increasing his direct common stock holdings to 49,747 shares.
On May 14, 2026, he received a new grant of 35,181 restricted stock units, each representing a contingent right to one share of common stock that vests at the close of business on May 14, 2027. The filing also notes 2,286 common stock warrants originally issued on October 7, 2025 as a pro‑rata distribution to all common shareholders, each with a $15.50 exercise price.
Bed Bath & Beyond director William Benjamin Nettles Jr. reported compensation-related equity transactions, with no open-market buying or selling. On May 15, 2026, restricted stock units covering 26,873 shares of common stock vested and were delivered, increasing his direct common stock holdings to 49,747 shares.
On May 14, 2026, he received a new grant of 35,181 restricted stock units, each representing a contingent right to one share of common stock that vests at the close of business on May 14, 2027. The filing also notes 2,286 common stock warrants originally issued on October 7, 2025 as a pro‑rata distribution to all common shareholders, each with a $15.50 exercise price.